Modulating Integrin Expression in Pancreatic Tumor Cells
ISEF · 2024 Cellular and Molecular Biology
Overview
Pancreatic Ductal Adenocarcinoma (PDAC) is a common type of pancreatic cancer and is characterized by a extremely high mortality rate. PDAC tumors tend to be extremely stiff, the reason for this is because the fibroblast-like cells release extra cellular matrix proteins in the tumor stroma which in turn stiffens the tumor. This stiff structure of the tumor can promote proliferation and metastasis of the cancer, and it can cause resistance to cancer drugs. In my research, I focused on Integrins, which are receptors for extracellular matrix proteins. I used the CRISPR a/i (activation/interference) system to modulate gene expression in Integrins. I analyzed the upregulation/downregulation of the modulation of gene expression by looking at cell morphology, proliferation, and other cellular mechanisms. My project provides insight on the physical/mechanical aspects of tumor formation and serves as a study to provide possible therapeutic intervention.
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2023
Modulation of EMT Gene Expression Using CRISPRa/i to Investigate Lung Cancer Mechanosensation
ISEF · 2022
Characterization of Lung Cancer Mechanosensation
ISEF · 2017
Modifying Substrate Mechanics to Bioengineer an in vitro Tumor Microenvironment
ISEF · 2014
MUC1 as a Biomarker for TGF-ß1 Inhibition: Investigating the Role of MUC1 in the Switch of TGF-ß1 Function from a Tumor Suppressor to a Tumor Promoter in Pancreatic Ductal Adenocarcinoma
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair